Browsing Category
24406 posts
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight
– ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted…